We found no significant relationship between fatty replacement and disease duration in anti‐TIF1‐γ‐positive DM in our analysis, which differed from sporadic inclusion body myositis (sIBM) and anti‐SRP myopathy. The gene discussed is TRIM33; the disease is myopathy.